Related references
Note: Only part of the references are listed.Erratum: Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
S J Gray et al.
GENE THERAPY (2013)
Amyotrophic lateral sclerosis
Albert C. Ludolph et al.
CURRENT OPINION IN NEUROLOGY (2012)
Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs
T. Federici et al.
GENE THERAPY (2012)
Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY (2012)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon Regrowth
Sang Ryong Kim et al.
MOLECULAR THERAPY (2012)
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Youngjin Lee et al.
NATURE (2012)
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Jean Bennett et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The common marmoset as a novel animal model system for biomedical and neuroscience research applications
Hideyuki Okano et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2012)
Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene Delivery
Brooke R. Snyder et al.
HUMAN GENE THERAPY (2011)
Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
Steven J. Gray et al.
HUMAN GENE THERAPY (2011)
RNAi medicine for the brain: progresses and challenges
Ryan L. Boudreau et al.
HUMAN MOLECULAR GENETICS (2011)
Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Steven J. Gray et al.
MOLECULAR THERAPY (2011)
Neuroprotection by Gene Therapy Targeting Mutant SOD1 in Individual Pools of Motor Neurons Does not Translate Into Therapeutic Benefit in fALS Mice
Chris Towne et al.
MOLECULAR THERAPY (2011)
Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
Adam K. Bevan et al.
MOLECULAR THERAPY (2011)
Several rAAV Vectors Efficiently Cross the Blood-brain Barrier and Transduce Neurons and Astrocytes in the Neonatal Mouse Central Nervous System
Hongwei Zhang et al.
MOLECULAR THERAPY (2011)
Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
Peter M. Andersen et al.
NATURE REVIEWS NEUROLOGY (2011)
Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo
Sophia T. Papadeas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Nerve Injection of Viral Vectors Efficiently Transfers Transgenes into Motor Neurons and Delivers RNAi Therapy Against ALS
Rui Wu et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Tailoring the AAV vector capsid for gene therapy
L. H. Vandenberghe et al.
GENE THERAPY (2009)
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Hristelina Ilieva et al.
JOURNAL OF CELL BIOLOGY (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression
Hongyan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
Jodi L. McBride et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Makiko Nagai et al.
NATURE NEUROSCIENCE (2007)
Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model
Francesco Paolo Di Giorgio et al.
NATURE NEUROSCIENCE (2007)
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9
Bassel Akache et al.
JOURNAL OF VIROLOGY (2006)
Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo
Xugang Xia et al.
NEUROBIOLOGY OF DISEASE (2006)
Antisense oligonucleotide therapy for neurodegenerative disease
Richard A. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates
GP Gao et al.
MOLECULAR THERAPY (2006)
New recombinant serotypes of AAV vectors
GP Gao et al.
CURRENT GENE THERAPY (2005)
Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model
GS Ralph et al.
NATURE MEDICINE (2005)
Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS
C Raoul et al.
NATURE MEDICINE (2005)
Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease
A Eslamboli et al.
JOURNAL OF NEUROSCIENCE (2005)
RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
HB Xia et al.
NATURE MEDICINE (2004)
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
M Azzouz et al.
NATURE (2004)
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model
BK Kaspar et al.
SCIENCE (2003)
Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis
HL Ding et al.
AGING CELL (2003)
Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus)
EC Maratos et al.
EXPERIMENTAL NEUROLOGY (2003)
Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets
S Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Aspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease
L Besret et al.
JOURNAL OF ANATOMY (2000)
Share Paper
